Neisseriaceae Infections - 25 Studies Found Status Study Completed Study Name: Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants Condition: Infections, Meningococcal Date: 2014-02-14 Interventions: Biological: Meningococcal group B Vaccine, rMenB+OMV NZ Completed Study Name: Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers Condition: Meningococcal Disease Date: 2013-11-11 Interventions: Biological: MenACWY-CRM MenACW Completed Study Name: Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180) Condition: Meningococcal Disease Date: 2013-11-15 Interventions: Biological: MenABCWY+OMV Vacci Completed Study Name: Testing the Use of Prompts to Increase Adolescent Immunization Rates Condition: Vaccine Preventable Diseases Meningococcal Disease Human P Date: 2013-11-07 Interventions: Other: Point-of-Care Prompt Completed Study Name: Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years. Condition: Meningococcal Disease Date: 2013-10-25 Interventions: Biological: Meningococcal B Recombinant vaccine rMenB+OMV NZ <<< Previous